We are live on ! Find out more
UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Portfolio holdings

AUM $863M
1-Year Est. Return 30.35%
This Fund
S&P 500
This Quarter Est. Return
+3.67%
1 Year Est. Return
+30.35%
3 Year Est. Return
+68.34%
5 Year Est. Return
+24.17%
10 Year Est. Return
–
AUM
$37.5M
AUM Growth
+$3.09M
Cap. Flow
+$3.37M
Cap. Flow %
8.97%
Top 10 Hldgs %
91.02%
Holding
32
New
10
Increased
4
Reduced
4
Closed
7

Top Buys

Rank Stock Value
1
SYRE icon
Spyre Therapeutics
SYRE
+$2.92M
2
ROK icon
Rockwell Automation
ROK
+$1.98M
3
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$930K
4
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$544K
5
VOE icon
Vanguard Morningstar Mid-Cap Value ETF
VOE
+$451K

Top Sells

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$1.68M
2
VDE icon
Vanguard Energy ETF
VDE
+$1.15M
3
VNQ icon
Vanguard Real Estate ETF
VNQ
+$650K
4
INTC icon
Intel
INTC
+$161K
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$159K

Sector Composition

Rank Sector Weight
1 Healthcare 26.89%
2 Energy 17.27%
3 Technology 6.02%
4 Industrials 5.52%
5 Materials 2.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WPZ
1
DELISTED
Williams Partners L.P.
WPZ
$6.42M 17.12%
172,732
– –
BPTH
2
DELISTED
Bio-Path Holdings Inc
BPTH
$5.33M 14.19%
958
– –
VEA icon
3
Vanguard FTSE Developed Markets ETF
VEA
$239B
$3.79M 10.09%
101,243
+25,296
+33% +$930K
VOE icon
4
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.5B
$3.38M 8.99%
36,067
+4,876
+16% +$451K
SYRE icon
5
Spyre Therapeutics
SYRE
$9.04B
$3.37M 8.97%
+20,997
New +$2.92M
VOO icon
6
Vanguard S&P 500 ETF
VOO
$1.04T
$3.36M 8.96%
16,932
+1,984
+13% +$393K
VWO icon
7
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$2.97M 7.91%
78,934
-2,389
-3% -$88.9K
TXN icon
8
Texas Instruments
TXN
$253B
$2.25M 5.99%
32,000
– –
ROK icon
9
Rockwell Automation
ROK
$49.6B
$2.07M 5.51%
+16,900
New +$1.98M
VDE icon
10
Vanguard Energy ETF
VDE
$10.4B
$1.23M 3.28%
12,579
-12,111
-49% -$1.15M
VNQ icon
11
Vanguard Real Estate ETF
VNQ
$39B
$919K 2.45%
10,593
-7,292
-41% -$650K
GMO
12
DELISTED
General Moly, Inc.
GMO
$819K 2.18%
2,922,831
– –
RETA
13
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$754K 2.01%
28,593
+27,434
+2,367% +$544K
LXRX icon
14
Lexicon Pharmaceuticals
LXRX
$1.06B
$645K 1.72%
35,714
– –
QQQ icon
15
Invesco QQQ Trust
QQQ
$486B
$59K 0.16%
+500
New +$57.7K
SCCO icon
16
Southern Copper
SCCO
$163B
$58K 0.15%
+2,402
New +$57.3K
KMI icon
17
Kinder Morgan
KMI
$70.7B
$51K 0.14%
+2,200
New +$46.6K
T icon
18
AT&T
T
$166B
$22K 0.06%
+720
New +$22.8K
CMCSA icon
19
Comcast
CMCSA
$91.7B
$11K 0.03%
+344
New +$11.4K
SLAB icon
20
Silicon Laboratories
SLAB
$7.31B
$9K 0.02%
+160
New +$8.64K
AAPL icon
21
Apple
AAPL
$4.43T
$5K 0.01%
+176
New +$4.66K
GOOG icon
22
Alphabet (Google) Class C
GOOG
$4.21T
$5K 0.01%
+140
New +$5.32K
POR icon
23
Portland General Electric
POR
$5.93B
$5K 0.01%
118
– –
XOM icon
24
ExxonMobil
XOM
$654B
$5K 0.01%
60
-40
-40% -$3.55K
EFX icon
25
Equifax
EFX
$21.2B
$4K 0.01%
29
– –
1
2

Similar funds

WFAL
Wedbush Fund Advisers, LLC Pasadena, California $863M AUM
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
OMG
One Madison Group New York $866M AUM 33.81% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
RWM
RMG Wealth Management Platteville, Wisconsin $866M AUM 11.95% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
HP
Havemeyer Place Greenwich, Connecticut $867M AUM
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s Q3 2016 Portfolio in Review

As of Q3 2016, University of Texas/Texas AM Investment Management Co (UTIMCO) held 32 positions worth $37.5M, up 9% from $34.4M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

University of Texas/Texas AM Investment Management Co (UTIMCO) deployed $3.37M of net new capital in Q3 2016, opening 10 new positions and adding to 4 existing holdings. Its largest new stake was Spyre Therapeutics: 20,997 shares worth $3.37M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Energy and Technology.

On the sell side, the largest reduction was Vanguard Energy ETF, an estimated $1.15M trimmed.

  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s largest Q3 2016 buy was Spyre Therapeutics: 20,997 shares worth $3.37M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) added most to Vanguard FTSE Developed Markets ETF in Q3 2016, an estimated $930K increase.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s biggest Q3 2016 reduction was Vanguard Energy ETF, cutting an estimated $1.15M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) fully exited Agios Pharmaceuticals in Q3 2016, selling an estimated $1.68M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s ten largest holdings make up 91% of its $37.5M portfolio in Q3 2016.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) opened 10 new positions and closed 7 in Q3 2016.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio value rose 9% quarter-over-quarter to $37.5M.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q3 2016, filed 3 Nov 2016.